The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ42 transgenic Drosophila and verification of its active ingredients

IntroductionThis study aims to establish the fingerprint spectra of Kai-Xin-San (KXS) and investigate its spectrum-effect relationship in treating Alzheimer’s disease (AD).MethodsInitially, the fingerprints of 15 batches of KXS were established and analyzed using HPLC, with the method’s precision, s...

Full description

Saved in:
Bibliographic Details
Main Authors: Jinfu Wu, Hang Sun, Yiyang Zhao, Lian Lian, Hongsheng Bian, Yong Guo, Dan Li, Lili Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1538837/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832583728335945728
author Jinfu Wu
Hang Sun
Yiyang Zhao
Lian Lian
Hongsheng Bian
Yong Guo
Dan Li
Lili Huang
author_facet Jinfu Wu
Hang Sun
Yiyang Zhao
Lian Lian
Hongsheng Bian
Yong Guo
Dan Li
Lili Huang
author_sort Jinfu Wu
collection DOAJ
description IntroductionThis study aims to establish the fingerprint spectra of Kai-Xin-San (KXS) and investigate its spectrum-effect relationship in treating Alzheimer’s disease (AD).MethodsInitially, the fingerprints of 15 batches of KXS were established and analyzed using HPLC, with the method’s precision, stability, and repeatability thoroughly evaluated. Subsequently, the effects of the 15 batches of KXS were assessed in an olfactory escape memory experiment, utilizing Aβ42 transgenic drosophila as a model. Finally, the spectrum-effect relationship between the KXS fingerprint and memory improvement was analyzed, with the active ingredients subjected to validation testing.ResultsThe results identified seventeen common peaks in the fingerprint, and eight active components were determined: polygalaxanthone III, 3-6-disinapoylsucrose, ginsenoside Rg1, ginsenoside Rb1, β-asarone, α-asarone, dehydrotumulosic acid, and dehydropachymic acid. Treatment with KXS (1%, for 4 days) significantly enhanced the performance index of Aβ42 flies in the olfactory experiment. Both spectrum-effect analysis and validation tests indicated that polygalaxanthone III, ginsenoside Rg1, ginsenoside Rb1, β-asarone, and α-asarone were positively correlated with the performance index and improved the performance index in the olfactory experiment. The HPLC fingerprint method for KXS demonstrated excellent precision, accuracy, and reproducibility, making it suitable for quality evaluation and control of KXS. Polygalaxanthone III, ginsenoside Rg1, ginsenoside Rb1, β-asarone, and α-asarone are identified as potential active ingredients of KXS for anti-AD effects.DiscussionThese findings provide an experimental basis for developing new drugs based on KXS and its active ingredient combinations.
format Article
id doaj-art-8ee7590d69034a8cb4dc17f344007f54
institution Kabale University
issn 1663-9812
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-8ee7590d69034a8cb4dc17f344007f542025-01-28T06:41:26ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-01-011610.3389/fphar.2025.15388371538837The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ42 transgenic Drosophila and verification of its active ingredientsJinfu Wu0Hang Sun1Yiyang Zhao2Lian Lian3Hongsheng Bian4Yong Guo5Dan Li6Lili Huang7College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, ChinaCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, ChinaCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, ChinaCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, ChinaCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, ChinaShineway Pharmaceutical Group Co., Ltd., Shijiazhuang, ChinaShineway Pharmaceutical Group Co., Ltd., Shijiazhuang, ChinaCollege of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, ChinaIntroductionThis study aims to establish the fingerprint spectra of Kai-Xin-San (KXS) and investigate its spectrum-effect relationship in treating Alzheimer’s disease (AD).MethodsInitially, the fingerprints of 15 batches of KXS were established and analyzed using HPLC, with the method’s precision, stability, and repeatability thoroughly evaluated. Subsequently, the effects of the 15 batches of KXS were assessed in an olfactory escape memory experiment, utilizing Aβ42 transgenic drosophila as a model. Finally, the spectrum-effect relationship between the KXS fingerprint and memory improvement was analyzed, with the active ingredients subjected to validation testing.ResultsThe results identified seventeen common peaks in the fingerprint, and eight active components were determined: polygalaxanthone III, 3-6-disinapoylsucrose, ginsenoside Rg1, ginsenoside Rb1, β-asarone, α-asarone, dehydrotumulosic acid, and dehydropachymic acid. Treatment with KXS (1%, for 4 days) significantly enhanced the performance index of Aβ42 flies in the olfactory experiment. Both spectrum-effect analysis and validation tests indicated that polygalaxanthone III, ginsenoside Rg1, ginsenoside Rb1, β-asarone, and α-asarone were positively correlated with the performance index and improved the performance index in the olfactory experiment. The HPLC fingerprint method for KXS demonstrated excellent precision, accuracy, and reproducibility, making it suitable for quality evaluation and control of KXS. Polygalaxanthone III, ginsenoside Rg1, ginsenoside Rb1, β-asarone, and α-asarone are identified as potential active ingredients of KXS for anti-AD effects.DiscussionThese findings provide an experimental basis for developing new drugs based on KXS and its active ingredient combinations.https://www.frontiersin.org/articles/10.3389/fphar.2025.1538837/fullKai-Xin-Sanspectrum-efficacy relationshipAlzheimer’s diseasepharmacodynamic material basisHPLCAβ42 transgenic Drosophila
spellingShingle Jinfu Wu
Hang Sun
Yiyang Zhao
Lian Lian
Hongsheng Bian
Yong Guo
Dan Li
Lili Huang
The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ42 transgenic Drosophila and verification of its active ingredients
Frontiers in Pharmacology
Kai-Xin-San
spectrum-efficacy relationship
Alzheimer’s disease
pharmacodynamic material basis
HPLC
Aβ42 transgenic Drosophila
title The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ42 transgenic Drosophila and verification of its active ingredients
title_full The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ42 transgenic Drosophila and verification of its active ingredients
title_fullStr The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ42 transgenic Drosophila and verification of its active ingredients
title_full_unstemmed The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ42 transgenic Drosophila and verification of its active ingredients
title_short The spectrum-efficacy correlation of Kai-Xin-San for cognition of Aβ42 transgenic Drosophila and verification of its active ingredients
title_sort spectrum efficacy correlation of kai xin san for cognition of aβ42 transgenic drosophila and verification of its active ingredients
topic Kai-Xin-San
spectrum-efficacy relationship
Alzheimer’s disease
pharmacodynamic material basis
HPLC
Aβ42 transgenic Drosophila
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1538837/full
work_keys_str_mv AT jinfuwu thespectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients
AT hangsun thespectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients
AT yiyangzhao thespectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients
AT lianlian thespectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients
AT hongshengbian thespectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients
AT yongguo thespectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients
AT danli thespectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients
AT lilihuang thespectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients
AT jinfuwu spectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients
AT hangsun spectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients
AT yiyangzhao spectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients
AT lianlian spectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients
AT hongshengbian spectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients
AT yongguo spectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients
AT danli spectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients
AT lilihuang spectrumefficacycorrelationofkaixinsanforcognitionofab42transgenicdrosophilaandverificationofitsactiveingredients